Orchestra BioMed (OBIO) CFO Taylor Lawrence Withholds 3,076 Shares for Taxes

What Happened
Taylor Andrew Lawrence, Chief Financial Officer of Orchestra BioMed (OBIO), reported a tax-withholding transaction on vested restricted stock units (RSUs). On 2026-08-26, 3,076 shares were withheld by the issuer at an effective price of $5.26 per share, totaling $16,180. The Form 4 lists this as a disposition (code F) to satisfy tax obligations; no open‑market sale occurred.

Key Details

• Transaction date: 2026-08-26; Form 4 filed: 2026-08-28 (appears timely).
• Amount: 3,076 shares withheld at $5.26 each — total value ~$16,180.
• Transaction code: F (withholding of shares to satisfy tax liability on RSU vesting).
• Footnote: F1 states shares were withheld by the issuer to satisfy tax withholding; no shares were sold in the market.
• Shares owned after transaction: not specified in the provided filing excerpt.

Context
This was a routine tax-withholding event tied to RSU vesting, not an open-market sale or purchase. Such withholdings are common and typically reflect tax compliance rather than a judgment about the company’s outlook. For full ownership details or additional transactions, check the complete Form 4 filing (Accession 0001104659-26-103210).